The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities

Table 1

Age-adjusted SEER incidence rates by age at diagnosis/death.

	Statistical probability of diagnosis
Woman’s age	<20	20–49	50–64	65–74	>75
Breast cancer	—	72.5	270	416	414
Cervical cancer	—	8.3	9.6	12	9.2
Colon cancer	—	10	60	152	270
Corpus and uterine cancer	—	9.4	66	95	73
Lung cancer	—	6.7	76	265	328
Melanoma	0.79	16	29	41	46
Ovarian cancer	0.42	5.8	27.9	41	49
Pancreatic cancer	—	1.4	14	45	79
Thyroid cancer	1.2	24	30	28	16
Vaginal cancer	—	—	1.2	2.5	3.3
Vulvar cancer	—	0.92	3.5	7.1	13

Informational source: Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2007. Bethesda, MD: National Cancer Institute, 2010.
“Incidence source: SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta). Rates are per 100,000 and are age-adjusted to the 2000 USA Std Population.”
— Statistics not displayed, <16 cases.